- Home
- BWA vs LEGN Comparison
BWA vs LEGN Comparison
Compare BWA & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWA
- LEGN
- Stock Information
- Founded
- BWA 1987
- LEGN 2014
- Country
- BWA United States
- LEGN United States
- Employees
- BWA N/A
- LEGN N/A
- Industry
- BWA Auto Parts:O.E.M.
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- BWA Consumer Discretionary
- LEGN Health Care
- Exchange
- BWA Nasdaq
- LEGN Nasdaq
- Market Cap
- BWA 6.3B
- LEGN 5.4B
- IPO Year
- BWA 1993
- LEGN 2020
- Fundamental
- Price
- BWA $44.02
- LEGN $36.08
- Analyst Decision
- BWA Buy
- LEGN Strong Buy
- Analyst Count
- BWA 14
- LEGN 12
- Target Price
- BWA $41.54
- LEGN $73.36
- AVG Volume (30 Days)
- BWA 2.4M
- LEGN 1.0M
- Earning Date
- BWA 10-30-2025
- LEGN 08-11-2025
- Dividend Yield
- BWA 1.54%
- LEGN N/A
- EPS Growth
- BWA N/A
- LEGN N/A
- EPS
- BWA 0.95
- LEGN N/A
- Revenue
- BWA $14,041,000,000.00
- LEGN $796,838,000.00
- Revenue This Year
- BWA $1.92
- LEGN $70.75
- Revenue Next Year
- BWA $2.95
- LEGN $52.47
- P/E Ratio
- BWA $44.14
- LEGN N/A
- Revenue Growth
- BWA N/A
- LEGN 74.75
- 52 Week Low
- BWA $24.40
- LEGN $27.34
- 52 Week High
- BWA $44.32
- LEGN $57.54
- Technical
- Relative Strength Index (RSI)
- BWA 76.20
- LEGN 48.36
- Support Level
- BWA $42.06
- LEGN $34.14
- Resistance Level
- BWA $43.83
- LEGN $36.17
- Average True Range (ATR)
- BWA 0.73
- LEGN 1.08
- MACD
- BWA -0.09
- LEGN 0.07
- Stochastic Oscillator
- BWA 89.98
- LEGN 48.67
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.